EUVIMEDEUVIMED entdecken
Open Access

Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests

Alexis Johnson, Rachel Thompson, Brooke Nickel, Patti Shih, Karin Hammarberg, Tessa Copp

JAMA Network Open · 21.08.2023 · 6 (8) · e2330192

DOI: 10.1001/jamanetworkopen.2023.30192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 21.08.2023. Verfasst von Alexis Johnson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Anti-Mullerian Hormone, Direct-to-Consumer Advertising, Reagent Kits, Diagnostic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The recent provision of direct-to-consumer (DTC) Anti-Mullerian Hormone (AMH) testing in several countries has been contentious, particularly due to concerns about judicious testing and informed consent.

Objective

To describe and analyze information on websites that sell DTC AMH tests. Design, Setting, and Participants Qualitative study including content analysis of text information from websites in multiple countries that sell AMH tests DTC. The top 50 search results from 4 different internet search strings were captured and reviewed for eligibility. Data were extracted in March 2022 and analyzed from April 2022 to July 2023. Main outcomes and measures Themes and categories were derived from the website content using a conventional inductive approach, with a particular focus on information content, quality and accuracy, as well as the tone and language used.

Results

Twenty-seven websites across 7 different countries formed the sample for analysis. Information varied considerably across websites and was organized into 6 overarching categories: (1) whether a test description was included (25 websites [93%]); (2) statements about what the test can do, which included indicating ovarian reserve (26 websites [96%]) and indicating likelihood of conceiving (20 websites [74%]); (3) statements about the usefulness of the test result, which included enabling women to adjust their reproductive timeline (11 websites [41%]) and determining whether egg freezing was a viable option (8 websites [30%]); (4) blood collection method (ie, through a laboratory or an at-home sample); (5) promotion tactics, such as stating the convenience of testing (24 websites [89%]) and using language promoting empowerment and control (7 websites [26%]); and (6) statements about limitations of the test, which included polycystic ovary syndrome falsely inflating AMH levels (13 websites [48%]) and that it cannot accurately predict chances of conceiving (9 websites [33%]). Conclusion and relevance In this qualitative study including content analysis, most websites selling DTC AMH tests included false and misleading claims which might lead consumers to purchase an AMH test in the belief that it can reliably predict fertility potential and age of menopause. Depending on the test result, this may in turn lead to misplaced anxiety or reassurance about one’s fertility and modifications to subsequent conception or contraceptive plans and behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Mullerian HormoneDirect-to-Consumer AdvertisingReagent Kits, DiagnosticFemaleHumansFertilityCommerceInternet

Substanzen

Anti-Mullerian HormoneReagent Kits, Diagnostic

Autor:innen und Institutionen

  • Faculty of Medicine and Health, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, Sydney, New South Wales, Australia.
  • Faculty of Arts, Social Sciences and Humanities, School of Health and Society, Australian Centre for Health Engagement, Evidence and Values, University of Wollongong, Wollongong, New South Wales, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Zitieren

APA

Johnson, A., Thompson, R., Nickel, B., Shih, P., Hammarberg, K., & Copp, T. (2023). Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests. JAMA Network Open, 6(8), e2330192. https://doi.org/10.1001/jamanetworkopen.2023.30192

Vancouver

Johnson A, Thompson R, Nickel B, Shih P, Hammarberg K, Copp T. Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests. JAMA Network Open. 2023;6(8):e2330192. doi:10.1001/jamanetworkopen.2023.30192

BibTeX
@article{Johnson2023,
  author = {Johnson, Alexis and Thompson, Rachel and Nickel, Brooke and Shih, Patti and Hammarberg, Karin and Copp, Tessa},
  title = {Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {8},
  pages = {e2330192},
  doi = {10.1001/jamanetworkopen.2023.30192}
}
Kostenlos starten →